Not applicableWithdrawnNCT04287686
What this trial is testing
Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19
Who this might be right for
COVID-19
The First Affiliated Hospital of Guangzhou Medical University